. 2022 Sep 2;171:105729. doi: 10.1016/j.micpath.2022.105729

Table 2.

Comparative effectiveness of one-dose vaccination regimens.

Disease	Complication	Sinopharm (N = 1317)		Pfizer (N = 320)		AstraZeneca (N = 380)		X² for “Disease”	X² for “Complications”
Disease	Complication	N	%	N	%	N	%	X² for “Disease”	X² for “Complications”
Cardiovascular diseases	Death	178	13.53	44	13.75	51	13.39	0.012	0.077
	Infected without hospitalization	139	10.56	34	10.63	41	10.76
	Infected with hospitalization	243	18.47	59	18.44	70	18.37
Respiratory diseases	Death	269	20.44	65	20.31	78	20.47	0.020	0.007
	Infected without hospitalization	9	0.68	2	0.63	3	0.79
	Infected with hospitalization	331	25.15	81	25.31	95	24.93
Diabetes	Death	9	0.68	2	0.63	3	0.79	0.172	0.101
	Infected without hospitalization	105	7.98	26	8.13	30	7.87
	Infected with hospitalization	33	2.51	7	2.19	10	2.62

No significant differences were found between all 3 vaccines regarding the mortality or morbidity in patients with chronic diseases.